Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPOLIZUMAB for Nasal polyps: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 757 adverse event reports in the FDA FAERS database where MEPOLIZUMAB was used for Nasal polyps.

Most Reported Side Effects for MEPOLIZUMAB

Side Effect Reports % Deaths Hosp.
Asthma 11,033 25.7% 290 6,026
Dyspnoea 9,192 21.4% 567 4,811
Wheezing 6,093 14.2% 552 3,335
Product dose omission issue 5,873 13.7% 88 957
Cough 4,577 10.6% 46 2,079
Pneumonia 4,107 9.6% 577 2,517
Therapeutic product effect incomplete 4,106 9.6% 347 2,064
Drug ineffective 3,880 9.0% 565 1,808
Loss of personal independence in daily activities 3,566 8.3% 179 2,015
Fatigue 2,656 6.2% 479 1,221
Off label use 2,614 6.1% 788 938
Sleep disorder due to a general medical condition 2,574 6.0% 104 1,406
Malaise 2,445 5.7% 392 1,248
Condition aggravated 2,304 5.4% 581 1,224
Headache 2,290 5.3% 379 951

Other Indications for MEPOLIZUMAB

Asthma (26,352) Product used for unknown indication (13,798) Eosinophilic granulomatosis with polyangiitis (1,224) Illness (372) Hypereosinophilic syndrome (351) Chronic obstructive pulmonary disease (291) Chronic rhinosinusitis with nasal polyps (122) Eosinophilia (102) Chronic sinusitis (71) Pulmonary vasculitis (62)

Other Drugs Used for Nasal polyps

DUPILUMAB (21,908) FLUTICASONE (449) MOMETASONE FUROATE (236) OMALIZUMAB (168) BUDESONIDE (46) MONTELUKAST (31) TRIAMCINOLONE ACETONIDE (26) PREDNISOLONE (23) BENRALIZUMAB (22) FLUTICASONE FUROATE (22)

Related Pages

MEPOLIZUMAB Full Profile All Nasal polyps Drugs MEPOLIZUMAB Demographics MEPOLIZUMAB Timeline